Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Tuesday, January 24 2017 8:15pm ET - U.S. Markets Closed.
Industry Center - Research Services
Industry Center > Research Services
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Business Services
· Consumer Services
· Education & Training Services
· Management Services
· Staffing & Outsourcing Services
· Technical Services
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Research Services
Composite Value: 840.8
Today's Change: +0.51%
S&P 500: +0.43%
chart for
[Research Services (^YHOh869)]
Research Services News
Singulex Enters into Collaboration with QIAGEN to Develop Companion Diagnostics
Tue Jan 10 (PR Newswire)
ALAMEDA, Calif., Jan. 10, 2017 /PRNewswire/ -- Singulex, Inc. today announced that it has entered into a strategic collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) focused on ...
The EndoPredict® Test Receives Positive Coverage Decisions from Multiple Blue Cross Blue Shield Affiliate Plans - (GlobeNewswire)
EndoPredict® Reviewed by Blue Cross Blue Shield Association’s Evidence Street - (GlobeNewswire)
More News on Research Services: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
Qiagen N.V. [QGEN] -1.26% $6.5 B
INC Research Holdings, Inc. [INCR] +0.89% $2.7 B
Myriad Genetics, Inc. [MYGN] +0.57% $1.1 B
National Research Corporation [NRCIB] 0.00% $978.8 M
Forrester Research, Inc. [FORR] -1.34% $737.8 M
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
02/01/17 QGEN Qiagen NV Q4 2016 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
01/18/17 MYGN Myriad Genetics, Inc. coverage initiated by Deutsche Bank
12/20/16 INCR INC Research Holdings, Inc. coverage initiated by First Analysis Sec
11/09/16 CDNA CareDx, Inc. upside earnings surprise (+40.00%)
More Recent Events...
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:12B
Price / Earnings:49.9
Price / Book:152.3
Net Profit Margin (mrq):6.5%
Price To Free Cash Flow (mrq):63.8
Return on Equity:7.4%
Total Debt / Equity:55.1
Dividend Yield:2.2%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
GPRO
SFCC
GTF
Unusually Active Boards
Board Variance
GTF
SFCC
EXEL

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Research Services Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?